Stockreport

Esperion Therapeutics: Past The Turnaround, Waiting On Guidelines [Seeking Alpha]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF ESPR has resolved generic threats, expanded labels, improved commercial traction, and strengthened its balance sheet, but royalty and debt burdens persist. Prescripti [Read more]